You just read:

Asterias Biotherapeutics Reports Second Quarter Results and Highlights Progress of SCiSTAR Study Evaluating AST-OPC1 in Spinal Cord Injury Patients

News provided by

Asterias Biotherapeutics, Inc.

15 Aug, 2016, 16:01 ET